Tissium Raises €50M in Series C Financing

31 Aug, 2021

Tissium Raises €50M in Series C Financing
Photo by Robert Bye on Unsplash

– Tissium is a medtech company developing biomorphic programmable polymers for tissue reconstruction.
– Company raised €50M in Series C financing.
– The round was led by Cathay Health, affiliated to global investment firm Cathay Capital, with participation from existing shareholders Sofinnova Partners, and others.
– The company intends to use the funds to continue to execute on its development plan, up to the commercialization of its nerve repair, hernia repair and cardiovascular sealant products.

Biotechnology Health Care Medical Device Western Europe
Crunchbase icon

Content report

The following text will be sent to our editors: